Home/Filings/4/0001156039-24-000027
4//SEC Filing

Kaye Mark 4

Accession 0001156039-24-000027

CIK 0001156039other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:22 PM ET

Size

7.2 KB

Accession

0001156039-24-000027

Insider Transaction Report

Form 4
Period: 2024-03-01
Kaye Mark
EVP & CFO
Transactions
  • Award

    Common Stock

    2024-03-01+2,75523,031 total
  • Award

    Employee Stock Option (Right to Buy)

    2024-03-01+10,63310,633 total
    Exercise: $499.11Exp: 2034-03-01Common Stock (10,633 underlying)
Footnotes (2)
  • [F1]Represents restricted share units. Restrictions lapse as follows: 918 shares each on 3/1/2025 and 3/1/2026 and 919 shares on 3/1/2027.
  • [F2]The option represents a right to purchase a total of 10,633 shares, and is exercisable in two installments of 3,544 shares each, and one installment of 3,545 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.

Issuer

Elevance Health, Inc.

CIK 0001156039

Entity typeother

Related Parties

1
  • filerCIK 0001748691

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:22 PM ET
Size
7.2 KB